QIBGX
Price
$23.87
Change
+$0.08 (+0.34%)
Updated
Oct 8 closing price
Net Assets
297.38M
RLBAX
Price
$38.73
Change
+$0.17 (+0.44%)
Updated
Oct 8 closing price
Net Assets
266.1B
Interact to see
Advertisement

QIBGX vs RLBAX

Header iconQIBGX vs RLBAX Comparison
Open Charts QIBGX vs RLBAXBanner chart's image
Federated Hermes MDT Balanced IS
Price$23.87
Change+$0.08 (+0.34%)
VolumeN/A
Net Assets297.38M
American Funds American Balanced R1
Price$38.73
Change+$0.17 (+0.44%)
VolumeN/A
Net Assets266.1B
QIBGX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
QIBGX vs. RLBAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QIBGX is a Buy and RLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. QIBGX (297M). QIBGX pays higher dividends than RLBAX: QIBGX (1.39) vs RLBAX (1.10). QIBGX was incepted earlier than RLBAX: QIBGX (23 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than QIBGX (1.12). QIBGX is a more actively managed with annual turnover of: 68.00 vs. RLBAX (44.00). RLBAX has a lower initial minimum investment than QIBGX: RLBAX (250) vs QIBGX (1000000). RLBAX annual gain was more profitable for investors over the last year : 9.08 vs. QIBGX (3.60). RLBAX return over 5 years is better than : 38.13 vs. QIBGX (24.84).
QIBGXRLBAXQIBGX / RLBAX
Total Expense Ratio1.091.3183%
Annual Report Gross Expense Ratio1.121.3185%
Fund Existence23 years23 years-
Gain YTD11.74314.27182%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets297M266B0%
Annual Yield % from dividends1.391.10126%
Returns for 1 year3.609.0840%
Returns for 3 years36.7648.6476%
Returns for 5 years24.8438.1365%
Returns for 10 years63.0069.4691%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVP0.990.01
+1.31%
Inspire Veterinary Partners Inc
GRRR20.220.23
+1.15%
Gorilla Technology Group
ROIV16.03-0.09
-0.56%
Roivant Sciences Ltd
PRLD1.42-0.02
-1.39%
Prelude Therapeutics
WLY36.77-1.56
-4.07%
John Wiley & Sons